MedTrace Logo

Obstetric Fecal Incontinence Treatment Registry

NCT04727463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-01-27

No results posted yet for this study

Summary

INTRODUCTION Anal Incontinence (AI) is a loose of voluntary control for bowel movements, with recurrent leaking of flatus, liquid or solid stools.

AI is a frecuent pathology. Prevalence is similar among men and women. AI´s ethiology is quite variable. Nevertheless, the most frecuent one is sphinteric injuries, obstetric, traumatic or secondary to anal surgery.

Conservative measures have to be iniciated and they are essential for every patient.

If a sphincteric injury exists, several choices of surgical treatment exist. The long term results obtained with sphincteroplasty, with a uniform surgical technique, follow up and complementing with other therapeutic options, has been considered interesting to analyze.

HYPOTHESIS Sphincteroplasty with the adoption of the appropriate complementary treatments, provides satisfactory results in the very long term, and should be considered as the procedure of choice in patients with Anal Incontinence.

OBJECTIVES

* Analyze the very long term results obtained with Sphincteroplasty as surgical technique for treatment of severe anal incontinence.
* Evaluate the results of the different types of surgical repair performed, according to the CCIS Score (Wexner Score).
* Evaluate the importance of patient follow-up and incorporation of complementary treatments.
* Establish patient´s satisfaction with the procedure after a long term follow up period after the intervention.

Conditions

  • Fecal Incontinence

Interventions

PROCEDURE

Sphincteroplasty

Overlapping sphincteroplasty

Sponsors & Collaborators

  • Hospital San Carlos, Madrid

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-16
Primary Completion
2020-12-16
Completion
2020-12-16

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04727463 on ClinicalTrials.gov